Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-679-1 | CAS number: 12023-27-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Diiron titanium pentaoxide is a mixed oxide of titanium dioxide (TiO2) and iron oxide (Fe2O3) , which are both considered not to be mutagenic. Pigments containing diiron titanium pentaoxide have been tested clearly negative in an Ames test (reference 7.6.1-1). Various in vitro genotoxicity studies have been performed with the read-across substances TiO2 and Fe2O3 showing no mutagenic, clastogenic or cell transforming activity.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- July 6, 2005 - August 19, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 2000
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- HIS operon (S. thyphimurium), TRP operon (E. coli)
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : liver S9 mix from Aroclor 1254-pretreated rats with standard co-factors
- method of preparation of S9 mix : Male Wistar rats, aged 6-8 weeks were given a single intraperitoneal injection of Aroclor 1254 (500 mg/kg bw) dissolved in Miglyol 812 oil. About 16 h before sacrifice, the rats remained without food. On day 5 or 7, they were sacrified, the livers were removed and collected in ice-cooled sterilized beakers containing 0.15 M KCl.
- concentration or volume of S9 mix and S9 in the final culture medium: 10% and 30% S9 in the S9 mix were used in the 1st and 2nd series
- quality controls of S9: metabolic capability was tested for each batch - Test concentrations with justification for top dose:
- 1st series: 5.00, 15.8, 50.0, 158, 500, 1580 and 5000 µg per plate (with and without metabolic activation)
2nd series: 50.0, 88.9, 158, 281 and 500 µg per plate (with and without metabolic activation) - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Daunomycin
- Remarks:
- without S9 mix, TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without S9 mix, TA1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- without S9 mix, TA1535, WP2 uvrA, TA100
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- with S9 mix, TA102
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cumene hydroperoxide
- Remarks:
- without S9 mix, TA102
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- with S9 mix, TA 98, TA100, TA1535, TA1537, WP2 uvrA
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments : two
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in agar (plate incorporation)
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 2 to 3 days at 37°C
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: background growth inhibition - Evaluation criteria:
- The evaluation of the results was performed according to predefined criteria. The definitions of "no", "clear" and "weak" have been defined depending on the historical controls of the laboratory.
A test material is defined as non-mutagenic in this assay if "no" or "weak increases" occur in the first and second series of the main experiment ("Weak increases" randomly occur due to experimental variation.)
A test material is defined as mutagenic in this assay if:
- a dose-related (over at least two test material concentrations) increase in the number of revertants is induced, the maximal effect is a "clear increase", and the effects are reproduced at similar concentration levels in the same test system;
- "clear increases" occur at least at one test material concentration, higher concentrations show strong precipitation or cytotoxicity, and the effects are reproduced at the same concentration level in the same test system.
In all further cases, a third test series with the bacterial strain in question should be performed.
If the criteria for a positive test result are not fulfilled in at least two out of the three series, the test material is defined as being non-mutagenic in this test system. - Statistics:
- no
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: Macroscopically visible precipitation of test material on agar plates occured at concentrations ≥500 µg/plate. Presumably, microscopic precipitation occured at all concentrations tested.
STUDY RESULTS
- Signs of toxicity : No toxicity to the bacteria was observed.
- Individual plate counts : see attached tables
- Genotoxicity results : see attached tables - Conclusions:
- With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Executive summary:
The investigations for the mutagenic potential of the test item were performed using according OECD TG 471 using Salmonella typhimurium tester strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coil WP2 uvrA. The plate incorporation test with and without addition of liver S9 mix from Aroclor 1254-pretreated rats was used. Two independent experimental series were performed. In the two series with S9 mix, 10 or 30 % S9 in the S9 mix were used in the 1st and 2nd series, respectively. The test item was suspended in DMSO and tested at concentrations ranging from 5.00 to 5000 µg/plate. At all concentration levels, the test material was plated as a suspension. Macroscopically visible precipitation of the test material on the agar plates occurred at concentrations >/= 500 µg/plate. Presumably, microscopic precipitation occured at all concentrations tested. Toxicity to the bacteria was not observed.
Daunomycin, N-ethyl-N'-nitro-N-nitrosoguanidine, 9-aminoacridine, and cumene hydroperoxide served as strain specific positive control test materials in the absence of S9 mix. 2-Aminoanthracene and benzo[a]pyrene were used for testing the bacteria and the activity of the S9 mix. Each treatment with the test materials used as positive controls led to a clear increase in revertant colonies, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used. With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Endpoint:
- in vitro DNA damage and/or repair study
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- accepted calculation method
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Genotoxic effects of Fe2O3 particles were determined by analyzing DNA fragmentation using the alkaline comet assay technique (pH 12.7).
- GLP compliance:
- not specified
- Remarks:
- No details on GLP status.
- Type of assay:
- comet assay
- Species / strain / cell type:
- mammalian cell line, other: BEAS-2B
- Details on mammalian cell type (if applicable):
- MEDIA USED
- Type and composition of media: DKSFM supplemented with 0.1% EGF protein and 1% antibiotics
- The cells were cultivated at 36°C and 5% CO2. - Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 10, 25, 50, and 250 µg/mL
- Vehicle / solvent:
- medium
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylnitrosurea
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 10E5 cells (BEAS-2B) were plated in Falcon T-25 flasks and preincubated for 24 h
- Test substance added in medium
Postexposure, the cells were washed, trypsinized, suspended in low melting agarose, and cast onto a gel bond film. Following the polymerization of the agarose, the cells were lysed overnight in freshly prepared and precooled cell lysis buffer. Electrophoresis of the lysed
cells was performed at a pH of 12.7 for 10 min (conditions: 300 mA, 1.5 V/cm at 4°C) following which the agarose was treated with neutralization solution for 30 min and dehydrated in absolute CH3COOH for 2 h. These agarose gels were dried in darkness overnight at 4°C and stained with SYBR-Green. Imaging and analysis were performed on a Leica microscope.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: Trypan blue assay - Evaluation criteria:
- The parameter of Olive tail moment was used for analysis of the DNA damage. The quantitative measurement of all the assays was expressed as mean percentage increase relative to unexposed control ± SD.
- Statistics:
- The results were statistically analyzed (exposure vs. negative control) using one-way ANOVA followed by Holm-Sidak post hoc test.
- Key result
- Species / strain:
- mammalian cell line, other: BEAS-2B
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >50 µg/mL
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Cyto- and genotoxicity caused by test item can only be observed at very high concentrations of >50 µg/mL. At occupationally relevant concentrations of < 10 µg/mL no cyto-and genotoxic effects can be observed.
- Executive summary:
Genotoxic effects of Fe2O3 particles were determined by analyzing DNA fragmentation using the alkaline comet assay technique (pH 12.7). Significant genotoxic effects were only found at very high particle concentrations (> 50 µg/mL) were high cytotoxicity have been observed. At occupationally relevant concentrations of < 10 µg/mL no cyto-and genotoxic effects can be observed.
- Endpoint:
- in vitro transformation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- accepted calculation method
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Investigations of transformation in the mouse embryo cell line BALB/3T3/A3 1-1-1 using various minerals.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian cell transformation assay
- Species / strain / cell type:
- mammalian cell line, other: BALB/3T3/A3 1-1-1
- Details on mammalian cell type (if applicable):
- The cells were cultured at 37°C and 5% C02 in Eagle’s minimal essential medium (MEM), supplemented with 10% fetal bovine serum (FBS, heat inactivated at 56°C for 30 min), 2 mM glutamine, and 50 pg/ml gentamicin (complete medium).
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 0, 12.5, 25, 50, 100 µg/cm2
- Vehicle / solvent:
- medium
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- not specified
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 10E4 cells per 50 mm dish
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 3 days
- Harvest time after the end of treatment: After 3 days exposure, medium was exchanged, which was changed twice weekly until 5 weeks from treatment, when the cultures were fixed and stained
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: relative colony forming efficiency (CFE) - Evaluation criteria:
- Morphologically transformed foci (type III) were scored when they showed densely aggregated or piled up cells, with a criss-cross growth pattern of spindle-shaped and hyperchromatic cells at the periphery of the focus. The number of transformed foci per 10E5 clonal survivors (as determined by the concurrent cytotoxicity assay) was used to estimate the transformation frequencies and their standard error.
- Species / strain:
- mammalian cell line, other: BALB/3T3/A3 1- 1-1
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not examined
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- not specified
- Conclusions:
- Fe2O3 shows no cytotoxicity and no transforming activity in the mouse embryo cell line BALB/3T3/A3 1-1-1.
- Executive summary:
The mouse embryo cell line BALB/3T3/A3 1-1-1 was incubated with Fe2O3 for 3 days using exposure concentrations of 0, 12.5, 25, 50, 100 µg/cm2. After 5 weeks from treatment the cultures were fixed and stained. Morphologically transformed foci were scored when they showed densely aggregated or piled up cells, with a criss-cross growth pattern of spindle-shaped and hyperchromatic cells at the periphery of the focus. The number of transformed foci per 10E5 clonal survivors (as determined by the concurrent cytotoxicity assay) was used to estimate the transformation frequencies. Fe2O3 shows no cytotoxicity and no transforming activity in the mouse embryo cell line BALB/3T3/A3 1-1-1.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Principles of method if other than guideline:
- Induction of sister chromatid exchange (SCE) and Chromosome Aberration (CA) in Chinese hamster ovary (CHO) cells in vitro.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- 0, 15, 20, 25 µg/mL (Chomosome Aberration test)
0, 2.5, 8.3, 25 µg/mL (SCE assay) - Vehicle / solvent:
- medium
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without S9 mix
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in medium
METHOD CHROMOSOMAL ABERRATION ASSAY
- Exposure duration/duration of treatment: without activation, cells were exposed to the test chemical for 8 hr, afterwards, test chemical was washed off, and the cells were treated with 0.1 µg/mL Colcemid for 2-2.5 hr
- Exposure duration/duration of treatment: with metabolic activation, cells were exposed to the test chemical plus the metabolic activation mixture for 2 hr, washed, incubated for 8 hr, and then treated with Colcemid for 2-2.5 hr
- Air-dried slides were coded and stained with Giemsa. One hundred to 200 cells from each of the three highest scorable doses were analyzed. All aberrations were individually classified (e.g., chromatid breaks, chromosome breaks, triradials), Gaps and endoreduplications were recorded
METHOD SCE ASSAY
- Exposure duration/duration of treatment: without metabolic activation, cells were exposed for approximately 25 hr; for the trials with metabolic activation the exposure was for 2 hr
- 10 µM bromodeoxyuridine was added 2 hr after dosing and cells were continuously exposed to BrdUrd up until the time of harvest with 0.1 µg/mL Colcemid present for the last 2-2.5 hr of incubation
- in cultures without activation the cells were washed to remove the test chemical prior to Colcemid addition (25 hr)
- In cultures with metabolic activation cells were washed to remove test chemical and the metabolic activation components 2 hr after the initial exposure
- mitotic cells were treated with 0.075 M KCl and fixed in 3:1 methanol:glacial acetic acid
- In order to evaluate cell cycle kinetics, slides from the highest doses were stained with Hoechst 33258 (0.5 µg/mL) and examined by fluorescence microscopy
- fifty cells were scored per dose in the initial trial, and, generally 25 were scored in the repeat trials. In those instances where the number of SCE/cell analyzed for a particular dose consistently exceeded the mean value of the high-dose positive control, only five to ten cells were scored - Evaluation criteria:
- A significant increase in the aberration assay was based on a binomial sampling assumption. An increase of 20% or greater increase in SCE per chromosome over the solvent control was considered significant.
- Statistics:
- Dunnett’s method
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Titanium dioxide did not induce SCE or chromosomal aberrations in vitro.
- Executive summary:
The in vitro genotoxicity of titanium dioxide was determined using the Sister-Chromatid Exchange (SCE) and Chromosome Aberration (CA) assay in Chinese hamster ovary cells (CHO). In the CA Assay the following concentrations have been tested: 0, 15, 20, and 25 µg/mL. In the SCE Assay 0, 2.5, 8.3 and 25 µg/mL have been used as test concentrations. The tests have been performed with and without exogenous metabolic activation (S9 mix). Titanium dioxide did not induce SCE or chromosomal aberrations; the high dose was limited by solubility. In the first aberration trial with activation, there was a positive response at 20 µg/mL; this response did not repeat in the subsequent trial, and the chemical was, therefore, judged to be negative.
- Endpoint:
- in vitro DNA damage and/or repair study
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Mutagenicity studies on various metal compounds.
- GLP compliance:
- no
- Type of assay:
- Bacillus subtilis recombination assay
- Species / strain / cell type:
- bacteria, other: B. subtilis H17 and M45
- Details on mammalian cell type (if applicable):
- Medium: B-2 broth (meat extract 10 g, polypeptone powder 10 g and NaCl 5 g in 1L, pH adjusted to 7.0)
- Additional strain / cell type characteristics:
- other: H17: (Rec+, arg- try-) M45: (Rec-, arg- try-)
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 0.05 mL-portions of metal solutions (0.005-0.5 M) were applied
- Vehicle / solvent:
- distilled water
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Details on test system and experimental conditions:
- On the day of the experiments, each stock of B. subtilis was melted and streaked radially from small pipettes onto B-2 agar. A 0.05-mL portion of test item was dropped onto a filter paper disk (diameter 10 mm), and the disk was placed on the starting point of the streak. The plates were kept at 4°C for 24 h and then incubated at 37°C overnight.
- Key result
- Species / strain:
- bacteria, other: B.subtilis
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- other: Strong positive rec effects were noted with compounds of arsenic and chromium.
- Conclusions:
- TiO2 gave a negative result in the rec-assay.
- Executive summary:
A recombination assay (rec-Assay) was carried out with 127 metal compounds including titanium dioxide using Bacillus subtilis to check their DNA-damaging capacity and mutagenicity. 0.05 mL-portions of metal solutions (0.005-0.5 M) were applied.TiO2 gave a negative result in the rec-assay.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Pigments containing diiron titanium pentaoxide have been tested clearly negative in an in vivo micronucleus assay in rats (reference 7.6.2-1). Furthermore, no mutagenic or clastogenic effects have been reported for both read-across substances TiO2 and Fe2O3 in vivo in the comet assay, the micronucleus test or the chromosome aberration assay.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 September 2000 - 2 October 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- HsdCpb:WU
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Wistar rats
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 264 - 299 g
- Housing: individually in Makrolon cages type 3
- Diet: ad libitum, Standard Diet from Eberle Nafag AG, Gossau, Switzerland
- Water: ad libitum, tap water
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 - 23.5
- Humidity (%): 57 - 62
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- 0.25% aqueous Methocel K4M Premium.
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test material group was dosed once with a limit dose of 2000 mg/kg bw.
Dosing volume: 10 mL/kg bw
Rats of the control group received the vehicle only. - Duration of treatment / exposure:
- The control and positive control were killed 24 hours after treatment.
The two test material groups were killed 24 and 48 hours after treatment. - Frequency of treatment:
- Single oral administration.
- Dose / conc.:
- 2 000 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5 males /vehicle control group
5 males/ positive control group
10 males/ test material group - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The animals of the positive control were orally treated with cyclophosphamide at a dose of 16.5 mg/kg bw.
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The highest dose given in the present study was selected to produce signs of toxicity but no mortality. Since the internationally valid guidelines recommend a maximum dose of 2000 mg/kg bw for this assay, 6 male and 6 female rats were treated orally with 2000 mg test item in preliminary range-finding experiments. No toxic effects were seen. For this reason, the dose of 2000 mg/kg body weight was selected as the highest, limit dose for male rats only in the main study of this investigation. The rats of the negative control group were treated orally with 10 mL of a 0.25 % aqueous MethocelR K4M premium solution. Animals of the positive control group received an oral dose of 16.5 mg cyclophosphamide/kg body weight With this dose a statistically significant increase in the number of polychromatic erythrocytes with micronuclei, as compared to the negative control, was to be expected.
TREATMENT AND SAMPLING TIMES
The control and positive control were killed 24 hours after treatment. The two test material groups were killed 24 and 48 hours after treatment.
DETAILS OF SLIDE PREPARATION
Immediately after the rats had been killed, one femur of each animal was dissected and cleaned from adherent muscles. The epiphyses were cut off and bone marrow cells were flushed out with fetal calf serum using a syringe, and suspended in the serum. This suspension was filtered through cellulose and centrifuged for 5 min at 150 x g. The sediment was resuspended in fetal calf serum and bone marrow smears were prepared from the resulting cell suspension. After 3 hours of drying, the slides were stained using Giemsa's solution with Weise buffer solution and mounted in Entellan.
METHOD OF ANALYSIS
A total of 2000 polychromatic erythrocytes per animal were scored for micronuclei using Zeiss light microscopes with plane optics (magnification: 1250x). Round particles with about 1/20 - 1/5 the diameter of an erythrocyte that stained violet, like nucleic
material, were scored as micronuclei. They were differentiated from granules by thorough examination at different optical levels. Only erythrocytes with a distinct bluish touch were evaluated as polychromatic. For determination of the quotient of normochromatic to polychromatic erythrocytes, both erythrocyte stages were screened for micronuclei and counted separately up to a total of 1000 erythrocytes per animal. Then counting was limited to polychromatic erythrocytes. - Evaluation criteria:
- A total of 2000 polychromatic erythrocytes (PCE) per animal were scored for micronuclei.
A positive effect in this test system is defined by the occurence of mean micronucleated PCEwhich are statistically significantly higher than those of the actual negative control, taking into account the historical negative controls of the laboratory. - Statistics:
- Exact Mann-Whitney-test.
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
No clinical findings were onserved in treated animals. No relevant treatment-related decrease in body weight was observed.
No statistically significant or biologically relevant increase in the number of polychromatic erythrocytes with micronuclei (MN-PCE) was observed. For the number of normochromatic cells with micronuclei, calculated per 1000 normochromatic erythrocytes by means of the above mentioned quotient, no increase was observed.
Quotient normochromatic : polychromatic erythrocytes:
No relevant treatment-related increase was observed for the test item - Conclusions:
- The test material was not mutagenic in the micronucleus assay in male rats under conditions where the positive control exerted potent mutagenic effects.
- Executive summary:
The test item was tested in an in vivo micronucleus assay in the rat. The test item was administered once orally by gavage to 10 male rats at the limit dose of 2000 mg/kg bw. A control group (5 animals) received the vehicle (0.25% aqueous Methocel®K4M premium) only. Cyclophosphamide was used as the positive substance (5 animals). Bone marrow smears were prepared from one femur of each animal and stained with Giemsa’s solution. For the test material group, preparation took place at two different times, i.e. 24 and 48 hours after administration of the test material. For the positive and negative control groups, the preparation time was 24 hours after start of the treatment. The number of polychromatic erythrocytes with micronuclei per 2000 polychromatic erythrocytes per animal was determined. The positive control showed the expected significant increase in the number of polychromatic erythrocytes with micronuclei. No statistically significant or biologically relevant increase in the number of polychromatic erythrocytes with micronuclei was observed in any of the pigment-treated groups. In conclusion, the test pigment item was not mutagenic in the micronucleus test in male rats under conditions of this study.
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The genotoxicity was evaluated at 6, 24, 48 and 72 h by the comet assay in leucocytes, 48 and 72 h by micronucleus test (MNT) in peripheral blood cells, 18 and 24 h by chromosomal aberration (CA) assay and 24 and 48 h by MNT in bonemarrow cells.
- GLP compliance:
- not specified
- Type of assay:
- mammalian comet assay
- Species:
- mouse
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: from National Institute of Nutrition,Hyderabad, India
- Age at study initiation: 6–8 weeks
- Weight at study initiation: 80–120 g
- Housing: animals were housed in groups of five in standard polypropylene cages with stainless steel top grill
- Diet: ad libitum, commercial pellet diet
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3
- Humidity (%): 55-65
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- Milli Q water
- Duration of treatment / exposure:
- single treatment
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Vehicle
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (40 mg/kg bw), given intraperitonially (i.p.) and the volume injected was 0.01 mL/g bw
- Tissues and cell types examined:
- peripheral blood
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Doses based on acute oral toxicity test.
TREATMENT AND SAMPLING TIMES: The peripheral blood was collected at 6, 24, 48 and 72 h after the dosing.
DETAILS OF SLIDE PREPARATION: Three slides were prepared for each experimental point. Cell viability was determined by trypan blue exclusion assay. The microscope slides were coated with 0.75% normal-melting-point agarose (NMPA) in PBS, 20 μL of heparinised peripheral blood wasmixed with 110 μL of 0.5% low-melting-point agarose (LMPA) in phosphate buffered saline (PBS) and applied to slides. The slides were coveredwith a cover slip and refrigerated for 5 min to solidified the gel. The cover slips were removed and slides were immersed for at least 1 h in ice-cold alkaline lysing solution
[2.5 M NaCl, 10 mM Tris, 100 mM ethylenediaminetetraacetic acid (EDTA), 10% dimethyl sulphoxide, 1% Triton X-100] at final pH 10.0.
METHOD OF ANALYSIS: electrophoresis at 25 V : 300 mA (1.25 V/cm) for 25 min
After electrophoresis, slides were neutralized with neutralizing buffer (Tris 0.4 M, pH 7.5) and then stained with ethidium bromide (20 μg/mL). One hundred cells per rat (50 cells analysed in each slide) were scored at 400× using a fluorescence microscope (Olympus-Japan) with a blue (488 nm) excitation filter and yellow (515 nm) emission (barrier) filter.
- Statistics:
- The statistical significant change in genotoxicity assays between treated and control groups were analyzed by one-way ANOVA. Multiple comparisons were performed by Tukey's test.
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
No statistically significant damage was observed at 6, 24, 48, 72 h sampling time in comparison to control (p>0.05). An intraperitoneal injection of CP (40 mg/kg) induced DNA damage in rat peripheral blood leukocytes. The mean % tail DNA was significantly (p<0.001) higher compared to control. - Conclusions:
- Fe2O3 was not genotoxic at the doses tested in an in vivo Comet Assay (peripheral blood).
- Executive summary:
An in vivo Comet Assay in leucocytes was conducted to assess the genotoxicity of Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 6, 24, 48 and 72 h by the comet assay in leucocytes.
No statistically significant damage was observed at 6, 24, 48, 72 h sampling time in comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage in rat peripheral blood leukocytes.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Principles of method if other than guideline:
- The genotoxicity was evaluated at 18 and 24 h by chromosomal aberration (CA) assay.
- GLP compliance:
- not specified
- Type of assay:
- mammalian bone marrow chromosome aberration test
- Species:
- mouse
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: from National Institute of Nutrition,Hyderabad, India
- Age at study initiation: 6–8 weeks
- Weight at study initiation: 80–120 g
- Housing: animals were housed in groups of five in standard polypropylene cages with stainless steel top grill
- Diet: ad libitum, commercial pellet diet
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3
- Humidity (%): 55-65
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- Milli Q water
- Duration of treatment / exposure:
- single treatment
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Vehicle
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (40 mg/kg bw), given intraperitonially (i.p.) and the volume injected was 0.01 mL/g bw
- Tissues and cell types examined:
- rat's bone marrow cells (femur and tibia)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Doses based on acute oral toxicity test.
TREATMENT AND SAMPLING TIMES: The analysis was carried out at two sampling of 18 and 24 h.
DETAILS OF SLIDE PREPARATION: The bone marrow was collected and centrifuged. Cells were then fixed through several changes of ice-cold methanol/glacial acetic acid (3:1, v/v) until the pellets were clean. After refrigeration for at least 24 h, cells were centrifuged and resuspended in fresh fixative, dropped onto slides, dried and stained with Geimsa. Three slides for each animal were made by the flame-dried technique.
METHOD OF ANALYSIS: on the basis of criteria established by the OECD Guideline 475
Five hundred well spread metaphases were selected to detect the presence of CAs; while the mitotic index (MI) was determined with 1000 or more cells at both the sampling times. - Statistics:
- The statistical significant change in genotoxicity assays between treated and control groups were analyzed by one-way ANOVA. Multiple comparisons were performed by Tukey's test.
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
Fe2O3 did not induce a dose dependent effect on the structural (gaps, breaks, minute, acentric fragment and reciprocal translocation) and numerical (aneuploidy and polyploidy) CAs as well as percentage (%) of aberrant cells at all the doses and treatment times. The total cytogenetic changes (numerical+structural CAs), total aberrations (structural aberrations) including and excluding gaps frequencies in Fe2O3 were well within normal control range, and were not significantly different (p>0.05) from concurrent controls. - Conclusions:
- Fe2O3 was not genotoxic at the doses tested in an in vivo Chromosomal Aberration Assay.
- Executive summary:
An in vivo Chromosom Aberration Assay was conducted to assess the genotoxicity of Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 18 and 24 hours by chromosomal aberration assay. No statistically significant damage was observed comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- The genotoxicity was evaluated at 48 and 72 h by micronucleus test (MNT) in peripheral blood cells and at 24 and 48 h by MNT in bonemarrow cells.
- GLP compliance:
- not specified
- Type of assay:
- mammalian bone marrow chromosome aberration test
- Species:
- mouse
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: from National Institute of Nutrition,Hyderabad, India
- Age at study initiation: 6–8 weeks
- Weight at study initiation: 80–120 g
- Housing: animals were housed in groups of five in standard polypropylene cages with stainless steel top grill
- Diet: ad libitum, commercial pellet diet
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3
- Humidity (%): 55-65
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- Milli Q water
- Duration of treatment / exposure:
- single treatment
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Vehicle
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (40 mg/kg bw), given intraperitonially (i.p.) and the volume injected was 0.01 mL/g bw
- Tissues and cell types examined:
- bonemarrow cells extracted from thigh bone
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Doses based on acute oral toxicity test.
TREATMENT AND SAMPLING TIMES: The study was done at 24 and 48 h of after treatment according to OECD Guideline 474
DETAILS OF SLIDE PREPARATION: The femurs were removed, the bone marrow was collected, centrifuged, spread on the slides and allowed to dry in humidified air overnight. The slides were fixed with methanol and stained with Giemsa (Sigma Chemical Co., St. Louis, MO) solution in phosphate buffer saline for the assessment of the micronuclei (MN) occurrence.
METHOD OF ANALYSIS: Three slidesweremade for each animal; the slideswere microscopically analyzed at 1000×magnification. Per animal, 2000 PCEs were randomly selected from three slides and scored for the presence of MN. - Statistics:
- The statistical significant change in genotoxicity assays between treated and control groups were analyzed by one-way ANOVA. Multiple comparisons were performed by Tukey's test.
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
The MN-PCEs frequencies in the Fe2O3 treated groups were very similar to those in controls and were not significantly different (p>0.05). On the other hand, CP (40 mg/kg bw) treated positive control groups induced a substantially significant (p<0.001) effect on MN-PCEs frequency. In the MNT with varied doses of test item exhibited no statistically difference in % PCEs with the negative control at 24 and 48 h after treatment, demonstrating the absence of bone marrow cytotoxicity.
The results from blood MNT: The % of PCEs in Fe2O3-treated groups of animals were not reduced at various doses (500, 1000, 2000 mg/kg bw). The data reveals that the compounds did not cause cytotoxicity. The MN-PCEs calculated after treatment with all the three doses did not show statistically significant differences (p>0.05) as compared to control at both the sampling times suggesting lack of clastogenicity. CP treated group showed significant difference (p<0.001) with respect to the control group. - Conclusions:
- Fe2O3 was not genotoxic at the doses tested in an in vivo Micronucleus Test (peripheral blood and bonemarrow).
- Executive summary:
An in vivo Micronucleus assay was conducted to assess the genotoxicity of Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 48 and 72 h by micronucleus test (MNT) in peripheral blood cells and 24 and 48 h by MNT in bonemarrow cells. No statistically significant damage was observed in comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage.
Referenceopen allclose all
Table 1: Results
Test material |
Dose |
Preparation |
MN-PCE [‰]a |
Solvent |
— |
24 |
0.40 |
Test item |
2000 |
24 |
0.40 |
Test item |
2000 |
48 |
0.80 |
Cyclophosphamide |
16.5 |
24 |
16.5* |
a:
Mean numbers of polychromatic erythrocytes with micronuclei per 1000 PCE
*: Statistically significant (p<0.01)
Table 1
Mean % tail DNA in peripheral blood leucocytes
|
mg/kg bw/day |
6 h |
24 h |
48 h |
72 h |
Control |
|
3.82 ±0.77 |
5.44 ±0.81 |
4.17 ±0.80 |
4.36±0.92 |
Fe203 |
500 |
3.77 ±0.47 |
4.81 ±59 |
4.08 ±0.67 |
3.46 ±0.47 |
|
1000 |
3.99 ±0.81 |
5.28 ±0.70 |
4.30 ±0.75 |
4.15 ±0.85 |
|
2000 |
4.01 ±0.69 |
5.61 ±0.86 |
4.59 ±0.88 |
4.29 ±0.77 |
CP (b) |
40 |
43.94 ±6.50 (c) |
54.56 ± 6.3 (c) |
25.39±4.65 (c) |
16.10±2.21 (c) |
a Cyclophosphamide (positive control), Data represented as mean±S.E., of 3 replicated experiments, 150 cells per
animal, n —5 animals, significantly different from control at Significantly different from control at c=p<0.001.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
A WoE Approach was used to investigate the genotoxicity of diiron titanium pentaoxide using data from pigments which contain diiron titanium pentaoxide (up to 37%) and data from the oxides titanium dioxide (TiO2) and iron oxide (Fe2O3). There are no data available for diiron titanium pentaoxide.
In vitro
The investigations for the mutagenic potential of the pigment (8-37% diiron titanium pentaoxide) were performed according OECD TG 471 using Salmonella typhimurium tester strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coli WP2 uvrA. The plate incorporation test with and without addition of liver S9 mix from Aroclor 1254-pretreated rats was used. Two independent experimental series were performed. In the two series with S9 mix, 10 or 30 % S9 in the S9 mix were used in the 1st and 2nd series, respectively. The test item was suspended in DMSO and tested at concentrations ranging from 5.00 to 5000 µg/plate. At all concentration levels, the test material was plated as a suspension. Macroscopically visible precipitation of the test material on the agar plates occurred at concentrations >/= 500 µg/plate. Presumably, microscopic precipitation occured at all concentrations tested. Toxicity to the bacteria was not observed. Daunomycin, N-ethyl-N'-nitro-N-nitrosoguanidine, 9-aminoacridine, and cumene hydroperoxide served as strain specific positive control test materials in the absence of S9 mix. 2-Aminoanthracene and benzo[a]pyrene were used for testing the bacteria and the activity of the S9 mix. Each treatment with the test materials used as positive controls led to a clear increase in revertant colonies, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used. With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
Furthermore, the in vitro genotoxicity of the read-across substance titanium dioxide was determined using the Sister-Chromatid Exchange (SCE) and Chromosome Aberration (CA) assay in Chinese hamster ovary cells (CHO). In the CA Assay the following concentrations have been tested: 0, 15, 20, and 25 µg/mL. In the SCE Assay 0, 2.5, 8.3 and 25 µg/mL have been used as test concentrations. The tests have been performed with and without exogenous metabolic activation (S9 mix). Titanium dioxide did not induce SCE or chromosomal aberrations; the high dose was limited by solubility. In the first aberration trial with activation, there was a positive response at 20 µg/mL; this response did not repeat in the subsequent trial, and the chemical was, therefore, judged to be negative.
A recombination assay (rec-Assay) was carried out with 127 metal compounds including titanium dioxide using Bacillus subtilis to check their DNA-damaging capacity and mutagenicity. 0.05 mL-portions of metal solutions (0.005-0.5 M) were applied.TiO2 gave a negative result in the rec-assay.
Genotoxic effects of Fe2O3 particles were determined by analyzing DNA fragmentation using the alkaline comet assay technique (pH 12.7). Significant genotoxic effects were only found at very high particle concentrations (> 50 µg/mL) were high cytotoxicity has been observed. At occupationally relevant concentrations of < 10 µg/mL no cyto-and genotoxic effects was be observed.
The mouse embryo cell line BALB/3T3/A3 1-1-1 was incubated with Fe2O3 for 3 days using exposure concentrations of 0, 12.5, 25, 50, 100 µg/cm2. After 5 weeks from treatment the cultures were fixed and stained. Morphologically transformed foci were scored when they showed densely aggregated or piled up cells, with a criss-cross growth pattern of spindle-shaped and hyperchromatic cells at the periphery of the focus. The number of transformed foci per 10E5 clonal survivors (as determined by the concurrent cytotoxicity assay) was used to estimate the transformation frequencies. Fe2O3 shows no cytotoxicity and no transforming activity in the mouse embryo cell line BALB/3T3/A3 1-1-1. In the same study TiO2 was tested and showed no transforming activity.
In vivo
The pigment containing 8 -37% diiron titanium pentaoxide was tested in an in vivo micronucleus assay according to OECD TG 474 in the rat. The test item was administered once orally by gavage to 10 male rats at the limit dose of 2000 mg/kg bw. A control group (5 animals) received the vehicle (0.25% aqueous Methocel®K4M premium) only. Cyclophosphamide was used as the positive substance (5 animals). Bone marrow smears were prepared from one femur of each animal and stained with Giemsa’s solution. For the test material group, preparation took place at two different times, i.e. 24 and 48 hours after administration of the test material. For the positive and negative control groups, the preparation time was 24 hours after start of the treatment. The number of polychromatic erythrocytes with micronuclei per 2000 polychromatic erythrocytes per animal was determined. The positive control showed the expected significant increase in the number of polychromatic erythrocytes with micronuclei. No statistically significant or biologically relevant increase in the number of polychromatic erythrocytes with micronuclei was observed in any of the pigment-treated groups. In conclusion, the test pigment item was not mutagenic in the micronucleus test in male rats under conditions of this study.
An in vivo Comet Assay in leucocytes was conducted to assess the genotoxicity of the read-across substance Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 6, 24, 48 and 72 h by the comet assay in leucocytes. No statistically significant damage was observed at 6, 24, 48, 72 h sampling time in comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage in rat peripheral blood leukocytes. In the same study, an in vivo Chromosome Aberration Assay was conducted to assess the genotoxicity of Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 18 and 24 hours by chromosomal aberration assay. No statistically significant damage was observed comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage.
An in vivo Micronucleus assay was conducted to assess the genotoxicity of Fe2O3 in female Wistar rats. The rats were treated orally with the single doses of 500, 1000, 2000 mg/kg bw and the genotoxicity was evaluated at 48 and 72 h by micronucleus test (MNT) in peripheral blood cells and 24 and 48 h by MNT in bonemarrow cells. No statistically significant damage was observed in comparison to control (p>0.05). An intraperitoneal injection of the positive control Cyclophosphamide (40 mg/kg) induced DNA damage.
Furthermore, male Sprague-Dawley rats were treated with Fe2O3 by intratracheal instillation of a suspension of iron oxide. The control group was treated with the vehicle (saline) only. 24h after treatment rats were sacrificed and cells were isolated (alveolar macrophages, lung cells, peripheral lymphocytes, hepatocytes. Alkaline single cell electrophoresis (comet assay) was performed. No statistically significant damage was observed in alveolar macrophages, lung cells, peripheral lymphocytes and hepatocytes from endotracheally treated rats sacrificed 24 h after treatment with test item compared with the control groups.
Therefore, based on the composition of the substance and the results obtained with TiO2, Fe2O3 and the pigment, diiron titanium pentaoxide is evaluated as not mutagenic.
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No 1272/2008
The available test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Thus, the test item is considered not to be classified for genotoxicity under Regulation (EC) No 1272/2008, as amended for the twelfth time in Regulation (EU) No 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.